scorecardresearch
Sunday, July 20, 2025
TopicGeneric drugs

Topic: Generic drugs

High demand, strict inspections — how Biden’s presidency could impact India’s pharma sector

US is the biggest market for Indian pharmaceutical companies and Biden's presidency is expected to bring with it some favourbable changes that could have a long-ranging impact.

Modi govt’s generic drugs scheme doubles sales to Rs 200 cr as branded variants see a fall

Modi govt is looking at total sales of Rs 500 cr in 2020-21 under Pradhan Mantri Bhartiya Janaushadhi Pariyojana, approximately 15% higher than last year’s Rs 433 cr.

How to study generic drugs for a better treatment of Covid-19

A focus on repurposing generic drugs would give researchers more shots on goal in the game of drug discovery, improving the odds that a winning treatment will emerge.

Modi govt refreshes plan to prioritise drug discovery, will launch hunt for ‘R&D head’

Modi govt’s efforts seek to address criticism lobbed at India for failing to discover even a single drug molecule despite being the largest producer of generic medicines in the world.

India wants concessions from US on drug exports, offers to cut farm goods prices, report says

Exclusive Reuters report says India, one of the largest consumers of dairy products, has proposed a quota-based system for US dairy imports.

Capping profits will wipe out low-cost generic medicines, drugmakers write to PM Modi

Trade bodies representing MSMEs write to PM after big players agreed to Modi govt’s proposal to cap trade margins for all medicines at 30% of MRP.

Why India is not ready for Modi government’s generic medicines-only diktat

Blatantly fostering generics will boomerang sooner or later if the regulatory system for quality checks is not made robust.

On Camera

Can Syria’s tiny Druze minority survive West Asia’s new storms? There’s little hope

Indians see West Asia as one uninterrupted wash of Islam, but the reality is more complex. For the Druze, support from Israel—where they are a recognised minority—is now critical.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

Not just AK-203, India & Russia to jointly manufacture AK-19 and PPK-20 for domestic use and export 

India-Russia JV is also racing to deliver 7,000 more AK-203 assault rifles by 15 Aug. These are currently being made with 50% indigenisation and this will surge to 100% by 31 December.

Strategic partner one day, tactical nightmare the next: India’s learning Trumplomacy the hard way

Public, loud, upfront, filled with impropriety and high praise sometimes laced with insults. This is what we call Trumplomacy. But the larger objective is the same: American supremacy.